Skip Navigation
Skip to contents




12 results

The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression


  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):72-73.
No abstract available.
A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naive Patient with Two Years of Follow Up

Goyal R, Devi SH

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):69-71.
Tardive dyskinesia (TD) is arguably the most serious and potential irreversible side effect of antipsychotic medication. Traditionally first generation antipsychotics are the neuroleptics considered to have higher risk of TD...
A Case of Acute Pancreatitis Associated with Risperidone Treatment

Kawabe K, Ueno SI

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):67-68.
Acute pancreatitis with antipsychotic treatment is rare but sometimes causes a fatal adverse effect. Most cases of acute pancreatitis due to atypical antipsychotic agents are reported to occur within six...
Successful Treatment of Anorexia Nervosa in a 10-year-old Boy with Risperidone Long-acting Injection

Umehara H, Iga J, Ohmori T

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):65-66.
Although the effectiveness of medication in the treatment of anorexia nervosa is uncertain, atypical antipsychotics such as olanzapine and risperidone have been used empirically for decades. we describe the case...
A Pilot Study for Discovering Candidate Genes of Chromosome 18q21 in Methamphetamine Abusers: Case-control Association Study

Lee BD, Park JM, Lee YM, Moon ES, Jeong HJ, Chung YI, Rim HD

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):54-64.
OBJECTIVE: It was previously suggested that the malic enzyme 2 (ME2) as the candidate gene for psychosis in fine mapping of chromosome 18q21. Chromosome 18q21 is also one of the...
Drug Treated Schizophrenia, Schizoaffective and Bipolar Disorder Patients Evaluated by qEEG Absolute Spectral Power and Mean Frequency Analysis

Wix-Ramos , Moreno X, Capote E, Gonzalez G, Uribe E, Eblen-Zajjur A

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):48-53.
OBJECTIVE: Research of electroencephalograph (EEG) power spectrum and mean frequency has shown inconsistent results in patients with schizophrenic, schizoaffective and bipolar disorders during medication when compared to normal subjects thus;...
Comparison of Memory Function and MMPI-2 Profile between Post-traumatic Stress Disorder and Adjustment Disorder after a Traffic Accident

Bae SM, Hyun MH, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):41-47.
OBJECTIVE: Differential diagnosis between post-traumatic stress disorder (PTSD) and adjustment disorder (AD) is rather difficult, but very important to the assignment of appropriate treatment and prognosis. This study investigated methods...
Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder

Atake K, Yoshimura , Hori H, Katsuki A, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):37-40.
OBJECTIVE: We investigated the effects of duloxetine on the plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor (BDNF) in 64 patients with major depressive disorder (MDD). METHODS: Major depressive...
Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-alpha Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration

Ma M, Ren Q, Zhang JC, Hashimoto

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):31-36.
OBJECTIVE: Accumulating evidence suggests that inflammation plays a role in the pathophysiology of major depression. The adenosine triphosphate (ATP)-sensitive P2X7 receptor (P2X7R) plays a crucial role in microglial activation caused...
Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder

Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, Shin CY, Cheon KA, Bahn GH

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):19-30.
In clinical practice, pharmacological treatment is mostly focused on behavioral symptoms in everyday life. Nevertheless, persistent effort continues to develop medication for causal treatment. Recent changes in diagnostic criteria from...
Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis

Venkatasubramanian G, Debnath M

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):8-18.
Within the wide-ranging gamut of factors that comprise gene-environment interactions postulated to underlie schizophrenia, the crosstalk between environmental factors and feto-maternal immune components has been put forth as one of...
Strategies for Early Non-response to Antipsychotic Drugs in the Treatment of Acute-phase Schizophrenia

Hatta K, Ito H

  • Clin Psychopharmacol Neurosci.
  • 2014 Apr;12(1):1-7.
As a strategy for antipsychotic treatment of schizophrenia, monotherapy is clearly optimal when both effective and tolerated. When a patient fails to respond to an adequate dose of an antipsychotic,...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: